John R Koethe1, Cathy A Jenkins, Bryan Lau, Bryan E Shepherd, William Wester, Peter F Rebeiro, Michael J Silverberg, Jennifer E Thorne, John Gill, Angel M Mayor, Amanda Willig, Ronald Bosch, Michael A Horberg, Amy C Justice, Timothy R Sterling, Richard D Moore. 1. *Departments of Medicine and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN; †Departments of Epidemiology and Medicine, Johns Hopkins University, Baltimore, MD; ‡Kaiser Permanente Northern California, Oakland, CA; §Southern Alberta HIV Clinic, Calgary, AB, Canada; ‖Department of Internal Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico; ¶Department of Medicine, University of Alabama at Birmingham, Birmingham, AL; #Department of Biostatistics, Harvard School of Public Health, Boston, MA; **Kaiser Permanente, Mid-Atlantic Permanente Research Institute, Rockville, MD; and ††Veterans Affairs Connecticut Healthcare System, West Haven, and Yale University School of Medicine and Public Health, New Haven, CT.
Abstract
BACKGROUND: Prior studies found overweight or obese HIV-infected individuals had greater early CD4 cell recovery on antiretroviral therapy (ART), but the results have been inconsistent. We assessed the longitudinal relationship between body mass index (BMI) and CD4 cell recovery on ART in a large, multisite cohort to identify potential physiologic links between adiposity and CD4 cell expansion. METHODS: We modeled the relationship of time-updated BMI with CD4 count in patients starting ART from 17 North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) cohorts. The primary analysis used a linear mixed effects model incorporating up to 13 years of data per patient and adjusted for age, sex, race, ART regimen, baseline CD4 count and other covariates. Sensitivity analyses limited the cohort to patients with sustained viral suppression or censored at virologic failure. RESULTS: Fourteen thousand eighty-four HIV-infected individuals initiating ART contributed data between 1998 and 2010. Time-updated BMI was significantly associated with CD4 cell recovery over time (P < 0.001). After 5 years of ART, the mean CD4 count at a BMI of 30 kg/m was 22% higher than at a BMI of 22 kg/m (606 vs. 498 cells per microliter) and 34% higher at a BMI of 40 kg/m (665 vs. 498 cells per microliter). Results were similar in the sensitivity analyses. DISCUSSION: Higher BMI is associated with long-term advantages in immune recovery on ART. Although it is unclear if this impacts health outcomes, including balancing the negative health effects of obesity, elucidating the underlying mechanism could identify therapies for patients with suboptimal immune reconstitution.
BACKGROUND: Prior studies found overweight or obese HIV-infected individuals had greater early CD4 cell recovery on antiretroviral therapy (ART), but the results have been inconsistent. We assessed the longitudinal relationship between body mass index (BMI) and CD4 cell recovery on ART in a large, multisite cohort to identify potential physiologic links between adiposity and CD4 cell expansion. METHODS: We modeled the relationship of time-updated BMI with CD4 count in patients starting ART from 17 North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) cohorts. The primary analysis used a linear mixed effects model incorporating up to 13 years of data per patient and adjusted for age, sex, race, ART regimen, baseline CD4 count and other covariates. Sensitivity analyses limited the cohort to patients with sustained viral suppression or censored at virologic failure. RESULTS: Fourteen thousand eighty-four HIV-infected individuals initiating ART contributed data between 1998 and 2010. Time-updated BMI was significantly associated with CD4 cell recovery over time (P < 0.001). After 5 years of ART, the mean CD4 count at a BMI of 30 kg/m was 22% higher than at a BMI of 22 kg/m (606 vs. 498 cells per microliter) and 34% higher at a BMI of 40 kg/m (665 vs. 498 cells per microliter). Results were similar in the sensitivity analyses. DISCUSSION: Higher BMI is associated with long-term advantages in immune recovery on ART. Although it is unclear if this impacts health outcomes, including balancing the negative health effects of obesity, elucidating the underlying mechanism could identify therapies for patients with suboptimal immune reconstitution.
Authors: Jennifer H Lee; Jean L Chan; Epaminondas Sourlas; Vassilios Raptopoulos; Christos S Mantzoros Journal: J Clin Endocrinol Metab Date: 2006-04-24 Impact factor: 5.958
Authors: G Shor-Posner; A Campa; G Zhang; N Persaud; M J Miguez-Burbano; J Quesada; M A Fletcher; J B Page; M K Baum Journal: J Acquir Immune Defic Syndr Date: 2000-01-01 Impact factor: 3.731
Authors: F Zhang; M B Basinski; J M Beals; S L Briggs; L M Churgay; D K Clawson; R D DiMarchi; T C Furman; J E Hale; H M Hsiung; B E Schoner; D P Smith; X Y Zhang; J P Wery; R W Schevitz Journal: Nature Date: 1997-05-08 Impact factor: 49.962
Authors: Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff Journal: Metabolism Date: 2007-07 Impact factor: 8.694
Authors: Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice Journal: Clin Infect Dis Date: 2015-03-11 Impact factor: 9.079
Authors: I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly Journal: J Clin Invest Date: 2002-10 Impact factor: 14.808
Authors: John R Koethe; Cathy A Jenkins; Briana D Furch; Jordan E Lake; Louise Barnett; Cindy C Hager; Rita Smith; Todd Hulgan; Bryan E Shepherd; Spyros A Kalams Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: David B Hanna; Molly Jung; Xiaonan Xue; Kathryn Anastos; Jennifer M Cocohoba; Mardge H Cohen; Elizabeth T Golub; Nancy A Hessol; Alexandra M Levine; Tracey E Wilson; Mary A Young; Robert C Kaplan Journal: AIDS Patient Care STDS Date: 2016-10 Impact factor: 5.078
Authors: Barbara S Taylor; Kaku So-Armah; Janet P Tate; Vincent C Marconi; John R Koethe; Roger J Bedimo; Adeel A Butt; Cynthia L Gibert; Matthew B Goetz; Maria C Rodriguez-Barradas; Julie A Womack; Mariana Gerschenson; Vincent Lo Re; David Rimland; Michael T Yin; David Leaf; Russell P Tracy; Amy C Justice; Matthew S Freiberg Journal: J Acquir Immune Defic Syndr Date: 2017-08-15 Impact factor: 3.731
Authors: Michael J A Reid; Sanjiv M Baxi; Lila A Sheira; Alan L Landay; Edward A Frongillo; Adebola Adedimeji; Mardge H Cohen; Eryka Wentz; Deborah R Gustafson; Daniel Merenstein; Peter W Hunt; Phyllis C Tien; Sheri D Weiser Journal: J Acquir Immune Defic Syndr Date: 2017-08-15 Impact factor: 3.731
Authors: Baba M Musa; Musa A Garbati; Ibrahim M Nashabaru; Shehu M Yusuf; Aisha M Nalado; Daiyabu A Ibrahim; Melynda N Simmons; Muktar H Aliyu Journal: Int Health Date: 2016-12-09 Impact factor: 2.473
Authors: Hubaida Fuseini; Ben A Gyan; George B Kyei; Douglas C Heimburger; John R Koethe Journal: Curr HIV/AIDS Rep Date: 2021-02-19 Impact factor: 5.071
Authors: W M Han; A Jiamsakul; J Jantarapakde; E Yunihastuti; J Y Choi; R Ditangco; R Chaiwarith; L P Sun; S Khusuwan; T P Merati; C D Do; I Azwa; M-P Lee; K Van Nguyen; Y-J Chan; S Kiertiburanakul; O T Ng; J Tanuma; S Pujari; F Zhang; Y M Gani; S Sangle; J Ross; N Kumarasamy Journal: HIV Med Date: 2020-11-17 Impact factor: 3.180
Authors: Stephanie A Ruderman; Heidi M Crane; Robin M Nance; Bridget M Whitney; Barbara N Harding; Kenneth H Mayer; Richard D Moore; Joseph J Eron; Elvin Geng; William C Mathews; B Rodriguez; Amanda L Willig; Greer A Burkholder; Sara Lindström; Brian R Wood; Ann C Collier; Vani Vannappagari; Cassidy Henegar; Jean Van Wyk; Lloyd Curtis; Michael S Saag; Mari M Kitahata; Joseph A C Delaney Journal: J Acquir Immune Defic Syndr Date: 2021-03-01 Impact factor: 3.771